FNY Investment Advisers »

Kezar Life Sciences shares owned by FNY Investment Advisers

Quarter-by-quarter ownership of Kezar Life Sciences (KZR) shares owned by FNY Investment Advisers from 13F filings

Historical chart of FNY Investment Advisers investment in Kezar Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Kezar Life Sciences held by FNY Investment Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kezar Life Sciences by FNY Investment Advisers

Quarter filed Position value Share count Share price at filing
2025-12-31 $314k 50k 6.28

More positions owned by FNY Investment Advisers

Cidara Therapeutics (CDTX)
Bank Of Montreal Cadcom (BMO)
Amplify Etf Tr (SILJ)
UnitedHealth (UNH)
Global X Fds global x copper (COPX)
Monolithic Power Systems (MPWR)
Morgan Stanley (MS)
Codere Online Luxembourg Ord (CDRO)
NVIDIA Corporation (NVDA)
Vaneck Vectors Gold Miners mutual (GDX)
Philip Morris International (PM)
Bleichroeder Acquisition Cor (BACQ)
Deere & Company (DE)
Futurecrest Acquisition Corp
Norfolk Southern (NSC)

View all positions for FNY Investment Advisers

Top funds holding Kezar Life Sciences

BML Capital Management
Tang Capital Management
Suvretta Capital Management
Stonepine Capital Management
Vanguard Group
OrbiMed Advisors
Acadian Asset Management
Peapod Lane Capital
ADAR1 Capital Management
Renaissance Technologies
Ikarian Capital
BlackRock
Qiming U.S. Ventures Management
Shay Capital
Geode Capital Management

View all funds holding Kezar Life Sciences